Both Upk1a and Upk1b were recently identified as useful IHC markers for the distinction of urothelial carcinomas from its morphological differential diagnoses in studies investigating 6929 [9] and 14,061 [10] tumors from more than 110 different cancer entities. This evidence concerns the gene UPK1A and urothelial carcinoma.